Kristen K Ciombor

6PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 07, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Kristen K Ciombor, Lianchun Xiao

|Jan 09, 2023
Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care?

Kristen K Ciombor, Cathy Eng

|Oct 17, 2022
Treatment of Metastatic Colorectal Cancer: ASCO Guideline.

Van K Morris, Erin B Kennedy, Nancy N Baxter

|Jun 01, 2022
BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape.

Kristen K Ciombor, John H Strickler, Tanios S Bekaii-Saab

|Jun 01, 2022
Anal Cancer: Emerging Standards in a Rare Disease.

Cathy Eng, Kristen K Ciombor, May Cho

|Jun 10, 2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Dung T Le, Jennifer N Durham, Kellie N Smith

Pageof 1

Frequent Collaborators

4 joint publications

Cathy Eng

3 joint publications

Van Karlyle Morris

3 joint publications

Al B Benson

2 joint publications

John H Strickler